Ameco Medical Industries

Ameco Medical Industries specialises in implantable double-lumen haemodialysis catheters, which are used for long-term vascular access in patients undergoing chronic dialysis. These catheters are designed to separate arterial and venous blood flow during haemodialysis procedures, ensuring efficient treatment. Their product line includes variations like split (e.g., Amecath X, Amecath Y) and dual-lumen (e.g., Amecath Twincath) configurations.

Ameco Medical Industries is based in the United States. Their devices are authorised for commercial distribution in the US through compliance with FDA regulations. The company’s products are listed in the FDA’s 510(k) and UDI registries, indicating their authorised status under US regulatory frameworks.

Ameco Medical Industries’ haemodialysis catheters fall under FDA Class II classification. This categorisation reflects their moderate risk level, requiring compliance with specific regulatory controls to ensure safety and effectiveness. Their devices are authorised via the 510(k) and De Novo pathways, which are standard routes for Class II medical devices in the US.

Ameco Medical Industries’ devices are included in the FDA’s 510(k) and Unique Device Identifier (UDI) registries. These registries document the authorised status of medical devices in the US, ensuring transparency and traceability for healthcare providers and regulators. Listing in these databases confirms compliance with FDA requirements for commercial distribution.